
Cade Hildreth, Founder: As 1ST and ONLY market research firm to specialize in the #stemcell industry, BioInformant is cited by the WSJ, Vogue, and Tony Robbins.
Washington, DC
Joined July 2014
- Tweets15.7K
- Following9.4K
- Followers18.8K
- Likes6.3K
[FLASH SALE] Global Database of Regenerative Medicine (RM) Industry Investors, 2027 – Featuring 300+ Investors - bioinformant.com/product/reg…
1
137
Hong Kong Startup MiCells® Selected for China Resources-HKSTP Programme as It Advances Private Blood Banking Technology bioinformant.com/micells-chi…
@Mi_cells is developing an asset-light, tech-driven approach to private blood banking, supported by patent-pending IP.
Ncardia Expands Neuroscience Portfolio with Six New Human iPSC-Derived Neuronal Models - bioinformant.com/ncardia-hum… @NcardiaStemCell
154
CellFiber Opens US Subsidiary in Philadelphia to Accelerate Scalable Manufacturing of iPSC, MSC, and CAR-T Cell Therapies - bioinformant.com/cellfiber-o…
1
310
Vector BioMed Selected as Top Lentiviral Vector Design and Manufacturing Company -bioinformant.com/vector-biom…
Life Sciences Review recognizes the pure-play lentiviral vector company’s work to help Asia-Pacific healthcare providers manufacture CAR-T therapies closer to patients.
1
158
The Exosome Revolution is Here: 1 in 7 Publications Emerged in the Past Year - bioinformant.com/what-are-ex…
210
Celaid Therapeutics Raises JPY 400 million in Series B Financing to Advance Ex Vivo Hematopoietic Stem Cell (HSC) Expansion - bioinformant.com/celaid-ther…
1
320
BioInformant retweeted
Evia Bio® Announces Availability of GMP-Grade CellShield™ MSC DMSO-Free Cryopreservation Media - bioinformant.com/evia-bio-gm…
Evia Bio, a leading provider of non-DMSO cryopreservation solutions, says the GMP grade of CellShield™ cryopreservation media is now available to customers.
Evia Bio® Announces Availability of GMP-Grade CellShield™ MSC DMSO-Free Cryopreservation Media - bioinformant.com/evia-bio-gm…
Evia Bio, a leading provider of non-DMSO cryopreservation solutions, says the GMP grade of CellShield™ cryopreservation media is now available to customers.
Basecamp Research Raises $140M to Advance AI-Designed In Vivo Cell Therapies - bioinformant.com/basecamp-re…
@Basecamp_Res
2
371
Cellares and Seoul National University Hospital Launch Proof-of-Concept for Automated Manufacturing of Gene-Modified HSPC Therapy on the Cell Shuttle® Platform - bioinformant.com/cellares-an…
@snuh_official
163
Made Scientific Expands U.S. GMP Cell Therapy Network with 85,000 Sq. Ft. Pennsylvania Acquisition — Operational on Day One - bioinformant.com/made-scient…
162
$600M in VC Funding. $1B Milestone Deals. The Exosome Market Is Accelerating. - bioinformant.com/600m-in-vc-…
@biotechne @EvOx_Ltd @Capricor @mdxhealth @thermofisher @exocobio @BenevSkincare @codiakbio
1
333
Designer Exosomes: How Engineered Vesicles Are Transforming Drug Delivery in 2027 - bioinformant.com/designer-ex…
@AnjariumBio @ArunA_Bio @AegleRxCorp @Capricor @codiakbio @EvOx_Ltd @OasisBiotech @riontx
How Human iPSCs are Revolutionizing Drug Discovery in 2027 - bioinformant.com/ipsc-drug-d…
@NcardiaStemCell @CellDynamics @bitbio @nexelbio @Evotec
288
Flip Mycoplasma delivers performance comparable with the best PCR tests in a ready to use format with results in just 12 min & a 3 step workflow, making easier to check your cultures before investing time in the next experiment.
Get a free sample kit flip-dx.com/mycoplasma
#Ad
168
I Peace Selected as a TOP 10 Awardee for the “Top 10 Longevity Breakthrough Awards 2026” - bioinformant.com/i-peace-top… @IPeaceInc_E
189
16 CAR-T Therapies and Counting:
How the CAR-T Market Is Evolving and The Companies Leading the Charge -bioinformant.com/globally-ap…
@Novartis @GileadSciences @bmsnews @LegendBiotech @JanssenUS @CARsgen_Ther @IASOBiosciences @ActImmuno @Immuneel_
Rose BioSolutions Debuts as Latest CGT CDMO Following GI Partners’ Acquisition of Charles River Businesses - bioinformant.com/rose-biosol…
282
Aspen Neuroscience Advances Sasineprocel, an Autologous iPSC-Based Therapy for Parkinson’s Disease, Toward Phase 3 - bioinformant.com/aspen-neuro…
@AspenNeuro
1
343

















